Chelation therapy and autism

BMJ 2006; 333 doi: https://doi.org/10.1136/bmj.333.7571.756 (Published 05 October 2006) Cite this as: BMJ 2006;333:756
  1. Yashwant Sinha, clinical trial physician (yashwanS@chw.edu.au),
  2. Natalie Silove, developmental paediatrician,
  3. Katrina Williams, community paediatrician
  1. Prince of Wales Hospital, Randwick, NSW 2031, Australia
  2. Child Development Unit, Children's Hospital at Westmead, Westmead, NSW, Australia
  3. Sydney Children's Hospital, Randwick, NSW, Australia

    EDITOR—More children are being diagnosed as having autism, and there are currently no treatments based on aetiology.1 Consequently, a number of controversial, unproved, alternative treatments have arisen. The recent death of an autistic child after a medication error with intravenous chelation therapy has brought one purported aetiology based treatment to international attention.2 The 5 year old child reportedly died from hypocalcaemia after …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription